7 / 11
Page 33
Journal of Clinical Nutrition & Dietetics
ISSN:2472-1921
3
r d
W o r l d C o n g r e s s o n
Nutrition, Dietetics
and Nutraceuticals
F e b r u a r y 2 5 - 2 6 , 2 0 1 9
P r a g u e , C z e c h R e p u b l i c
World Nutrition 2019
Y
ou are more bacteria than you are human with 10 trillion human cells
outnumbered by over 100 trillionbacteria cells in and on your body. The
human genome contributes just 1% genetic material to daily metabolic
function compared to the 99% that is contributed by the microbiome. An often-
overlooked role of the microbiome is to prevent post-prandial endotoxemia
and the inflammatory devastation that follows. This lecture will illustrate the
danger of having post-prandial endotoxemia and why this condition is being
called the number one cause of mortality worldwide as it sets up the body for
virtually every chronic disease. This condition is caused by eating and a failure
of the microbiome to protect its host from this response. You simply cannot
completely correct any chronic condition without addressing post-prandial
endotoxemia.
Topic overview
1. The latest understanding on the form and function of the human
microbiome
2. The development and establishment of the human microbiome and
factors that disrupt optimal development.
3. How the microbiome controls the immune system, the brain, the endocrine
system and nutrient production – the critical cross-talk between microbe
and host.
4. Understanding post-prandial endotoxemia (PPE) and its resulting effects
on the human body.
5. Strategies for probiotic therapy that can impact PPE
6. The role of transient, commensal spore based probiotics in bacteriotherapy
to treat PPE
Biography
Kiran Krishnan is a Research Microbiologist and has been
involved in the dietary supplement and nutrition market for the
past 18 years. He comes from a strict research background
having spent several years with hands-on R&D in the fields
of molecular medicine and microbiology at the University of
Iowa. Kiran established a Clinical Research Organization where
he designed and conducted dozens of human clinical trials in
human nutrition. Kiran is also a co-founder and partner in Nu
Science Trading, LLC.; a nutritional technology development
and research company. Kiran is also a co-founder and Chief
Scientific Officer at Microbiome Labs. In his career, he has
developed over 50 private label nutritional products for small to
large brands in the global market. He is a frequent lecturer on
the Human Microbiome at Medical and Nutrition Conferences.
He conducts a very popular Microbiome Series educational
Webinar, is an expert guest on National and Satellite radio, has
appeared in several international documentaries and has been
a guest speaker on several International Health Summits as a
microbiome expert. He is currently involved in 10 novel human
clinical trials on probiotics and the human microbiome. Kiran is
also on the Scientific Advisory Board or a Science Advisor for 7
other companies in the industry.
aly@gomegaspore.comThe spectacular role of the human microbiome in preventing
post-prandial or metabolic endotoxemia, the number one
cause of mortality worldwide
Kiran Krishnan
Microbiome Labs, USA
Kiran Krishnan, J Clin Nutr Diet 2019, Volume: 5
DOI: 10.4172/2472-1921-C1-005